Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Squinto Stephen P
Relationship:   Director, 10% Owner
City:   Cheshire
State:   CT
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   238,160    

Indirect Shares

   6,290,493      
Direct Value   $19,437,710    

Indirect Value

   $19,013,945      
Total Shares   6,528,653      
Total Value   $38,451,655      


Alexion Pharmaceuticals Inc $19,437,710 Springworks Therapeutics, Inc. $0 Alexion Pharmaceuticals Inc $19,437,710 Springworks Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alexion Pharmaceuticals Inc ALXN EVP, Chief Global Ops.... 2014-10-27 106,508 2013-10-28 104,186    Premium*  
            Springworks Therapeutics, Inc. SWTX Director, 10% Owner 2022-05-19 131,652 2022-05-19 6,186,307    Premium*  
* Premium Members only  

Records found :    148         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2009-01-16 4 S $36.81 $49,620 D/D (1,348) 25,590 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2009-07-10 4 S $36.93 $11,744 D/D (318) 28,250 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-03-12 4 AS $37.15 $28,160 D/D (758) 15,514 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2009-07-16 4 S $38.96 $12,350 D/D (317) 28,251 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2008-09-11 4 S $40.20 $12,824 D/D (319) 31,165 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2014-10-03 4 OE $42.66 $427,666 D/D 10,025 116,893 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2014-10-27 4 OE $42.66 $348,140 D/D 5,550 112,418 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2006-11-13 4 AS $42.76 $342,175 D/D (8,000) 12,272 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-04-03 4 AS $43.52 $413,673 D/D (9,500) 15,514 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2009-08-04 4 AS $45.00 $189,000 D/D (4,200) 28,251 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of R&D   •       –      –    2010-02-16 4 S $46.60 $745,600 D/D (16,000) 35,454 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of R&D   •       –      –    2010-01-19 4 S $47.22 $15,677 D/D (332) 26,454 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of R&D   •       –      –    2010-01-11 4 S $47.67 $69,837 D/D (1,465) 26,786 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-06-01 4 AS $48.50 $1,212,500 D/D (25,000) 25,014 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2011-07-11 4 S $50.00 $25,100 D/D (502) 78,270 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of R&D   •       –      –    2010-07-16 4 S $51.08 $16,959 D/D (332) 34,873 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of R&D   •       –      –    2010-07-12 4 S $51.91 $12,926 D/D (249) 35,205 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2008-03-10 4 S $56.05 $8,912 D/D (159) 15,901 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-07-25 4 AS $56.50 $1,414,306 D/D (25,000) 20,512 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2011-07-27 4 S $57.27 $38,314 D/D (669) 77,601 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2011-07-26 4 S $57.34 $1,605,520 D/D (28,000) 78,270 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of R&D   •       –      –    2010-09-13 4 S $60.89 $756,010 D/D (12,416) 34,873 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-09-10 4 AS $65.31 $13,650 D/D (209) 20,303 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2011-10-24 4 S $68.84 $3,654,394 D/D (52,740) 78,851 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2008-01-10 4 S $69.02 $49,142 D/D (712) 16,060 0 -
  148  Records found
  1   2   3   4  5   6      
  Page 4 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us